{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T20:26:39Z","timestamp":1648844799098},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2021,3,12]],"date-time":"2021-03-12T00:00:00Z","timestamp":1615507200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,3,12]],"date-time":"2021-03-12T00:00:00Z","timestamp":1615507200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Internist"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1007\/s00108-021-00994-2","type":"journal-article","created":{"date-parts":[[2021,3,12]],"date-time":"2021-03-12T13:02:52Z","timestamp":1615554172000},"page":"463-473","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Risikoassessment bei Osteoporose"],"prefix":"10.1007","volume":"62","author":[{"given":"Friederike","family":"Thomasius","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bj\u00f6rn","family":"B\u00fchring","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,3,12]]},"reference":[{"issue":"11","key":"994_CR1","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1359\/jbmr.2003.18.11.1947","volume":"18","author":"KL Stone","year":"2003","unstructured":"Stone\u00a0KL, Seeley\u00a0DG, Lui\u00a0LY, Cauley\u00a0JA, Ensrud\u00a0K, Browner\u00a0WS, Cummings\u00a0SR et al (2003) BMD at multiple sites and risk of fracture of multiple types: long-term results from the study of osteoporotic fractures. J\u00a0Bone Miner Res 18(11):1947\u20131954","journal-title":"J Bone Miner Res"},{"issue":"6","key":"994_CR2","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1503\/cmaj.070234","volume":"177","author":"A Cranney","year":"2007","unstructured":"Cranney\u00a0A, Jamal\u00a0SA, Tsang\u00a0JF, Josse\u00a0RG, Leslie\u00a0WD (2007) Low bone mineral density and fracture burden in postmenopausal women. CMAJ 177(6):575\u2013580","journal-title":"CMAJ"},{"key":"994_CR3","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1007\/s00198-007-0543-5","volume":"19","author":"JA Kanis","year":"2008","unstructured":"Kanis\u00a0JA, Johnell\u00a0O, Oden\u00a0A et\u00a0al (2008) FRAX\u2122 and the assessment of fracture probability in men and women from the UK. Osteoporos Int 19:385\u2013397","journal-title":"Osteoporos Int"},{"key":"994_CR4","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1007\/s11657-013-0166-8","volume":"9","author":"JA Kanis","year":"2014","unstructured":"Kanis\u00a0JA, Johansson\u00a0H, Oden\u00a0A et\u00a0al (2014) Worldwide uptake of FRAX. Arch Osteoporos 9:166","journal-title":"Arch Osteoporos"},{"issue":"1","key":"994_CR5","doi-asserted-by":"publisher","first-page":"46","DOI":"10.5152\/eurjrheum.2016.048","volume":"4","author":"T S\u00f6zen","year":"2017","unstructured":"S\u00f6zen\u00a0T, \u00d6z\u0131\u015f\u0131k\u00a0L, Ba\u015faran\u00a0N\u00c7 (2017) An overview and management of osteoporosis. Eur J Rheumatol 4(1):46\u201356","journal-title":"Eur. J. Rheumatol."},{"issue":"27","key":"994_CR6","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1055\/s-0038-1673537","volume":"3","author":"F Thomasius","year":"2018","unstructured":"Thomasius\u00a0F, Baum\u00a0E, Bernecker\u00a0P et\u00a0al (2018) DVO guideline 2017 for the prophylaxis, diagnosis and treatment of osteoporosis in postmenopausal women and men short version. Osteologie 3(27):154\u2013160","journal-title":"Osteologie"},{"issue":"3","key":"994_CR7","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s11914-009-0013-4","volume":"7","author":"EV McCloskey","year":"2009","unstructured":"McCloskey\u00a0EV et\u00a0al (2009) From relative risk to absolute fracture risk calculation: the FRAX algorithm. Curr Osteoporos Rep 7(3):77\u201383","journal-title":"Curr Osteoporos Rep"},{"issue":"4","key":"994_CR8","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1007\/s00198-007-0543-5","volume":"19","author":"JA Kanis","year":"2008","unstructured":"Kanis\u00a0JA et\u00a0al (2008) FRAX\u2122 and the assessment of fracture probability in men and women from the UK. Osteoporos Int 19(4):385\u2013397","journal-title":"Osteoporos Int"},{"key":"994_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00198-018-4712-5","volume":"30","author":"W Leslie","year":"2019","unstructured":"Leslie\u00a0W (2019) FRAX: a\u00a0coming of age. Osteoporos Int 30:1\u20132","journal-title":"Osteoporos Int"},{"key":"994_CR10","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/s00198-013-2460-0","volume":"25","author":"H Johansson","year":"2014","unstructured":"Johansson\u00a0H, Od\u00e9n\u00a0A, McCloskey\u00a0EV, Kanis\u00a0JA (2014) Mild morphometric vertebral fractures predict vertebral fractures but not non-vertebral fractures. Osteoporos Int 25:235\u2013241","journal-title":"Osteoporos Int"},{"key":"994_CR11","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1359\/jbmr.2000.15.6.993","volume":"15","author":"TP Van Staa","year":"2000","unstructured":"Van Staa\u00a0TP, Leufkens\u00a0HG, Abenhaim\u00a0L, Zhang\u00a0B, Cooper\u00a0C (2000) Use of oral corticosteroids and risk of fractures. J\u00a0Bone Miner Res 15:993\u20131000","journal-title":"J Bone Miner Res"},{"issue":"12","key":"994_CR12","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1007\/s00198-005-1909-1","volume":"16","author":"II de Liefde","year":"2005","unstructured":"de Liefde\u00a0II et al (2005) Bone mineral density and fracture risk in type\u20112 diabetes mellitus: the Rotterdam study. Osteoporos Int 16(12):1713\u20131720","journal-title":"Osteoporos Int"},{"issue":"3","key":"994_CR13","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/s00198-003-1514-0","volume":"15","author":"O Johnell","year":"2004","unstructured":"Johnell\u00a0O et\u00a0al (2004) Fracture risk following an osteoporotic fracture. Osteoporos Int 15(3):175\u2013179","journal-title":"Osteoporos Int"},{"issue":"2","key":"994_CR14","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.bone.2004.03.024","volume":"35","author":"JA Kanis","year":"2004","unstructured":"Kanis\u00a0JA et al (2004) A meta-analysis of previous fracture and subsequent fracture risk. Bone 35(2):375\u2013382","journal-title":"Bone"},{"key":"994_CR15","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1007\/s00198-018-4502-0","volume":"29","author":"JA Kanis","year":"2018","unstructured":"Kanis\u00a0JA, Johansson\u00a0H, Od\u00e9n\u00a0A, Harvey\u00a0NC, Gudnason\u00a0V, Sanders\u00a0KM, Sigurdsson\u00a0G, Siggeirsdottir\u00a0K, Fitzpatrick\u00a0LA, Borgstr\u00f6m\u00a0F, McCloskey\u00a0EV (2018) Characteristics of recurrent fractures. Osteoporos Int 29:1747\u20131757","journal-title":"Osteoporos Int"},{"key":"994_CR16","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1007\/s00198-020-05294-3","volume":"31","author":"R Barron","year":"2020","unstructured":"Barron\u00a0R, Oster\u00a0G, Grauer\u00a0A et\u00a0al (2020) Determinants of imminent fracture risk in postmenopausal women with osteoporosis. Osteoporos Int 31:2103\u20132111","journal-title":"Osteoporos Int"},{"key":"994_CR17","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1007\/s00198-019-05274-2","volume":"31","author":"WD Leslie","year":"2020","unstructured":"Leslie\u00a0WD, Schousboe\u00a0JT, Morin\u00a0SN et al (2020) Fracture risk following high-trauma versus low-trauma fracture: a\u00a0registry-based cohort study. Osteoporos Int 31:1059\u20131067","journal-title":"Osteoporos Int"},{"key":"994_CR18","doi-asserted-by":"publisher","first-page":"2381","DOI":"10.1001\/jama.298.20.2381","volume":"298","author":"DC Mackey","year":"2007","unstructured":"Mackey\u00a0DC, Lui\u00a0LY, Cawthon\u00a0PM, Bauer\u00a0DC, Nevitt\u00a0MC, Cauley\u00a0JA, Hillier\u00a0TA, Lewis\u00a0CE, Barrett-Connor\u00a0E, Cummings\u00a0SR, Study of Osteoporotic Fractures (SOF), Osteoporotic Fractures in Men Study (MrOS) Research Groups (2007) High-trauma fractures and low bone mineral density in older women and men. JAMA 298:2381\u20132388","journal-title":"JAMA"},{"issue":"8","key":"994_CR19","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1359\/jbmr.1998.13.8.1337","volume":"13","author":"KM Sanders","year":"1998","unstructured":"Sanders\u00a0KM, Pasco\u00a0JA, Ugoni\u00a0AM, Nicholson\u00a0GC, Seeman\u00a0E, Martin\u00a0TJ et\u00a0al (1998) The exclusion of high trauma fractures may underestimate the prevalence of bone fragility fractures in the community: the Geelong osteoporosis study. J\u00a0Bone Miner Res 13(8):1337\u20131342","journal-title":"J Bone Miner Res"},{"key":"994_CR20","doi-asserted-by":"publisher","first-page":"2411","DOI":"10.1002\/jbmr.446","volume":"26","author":"DC Mackey","year":"2011","unstructured":"Mackey\u00a0DC, Black\u00a0DM, Bauer\u00a0DC, McCloskey\u00a0EV, Eastell\u00a0R, Mesenbrink\u00a0P, Thompson\u00a0JR, Cummings\u00a0SR (2011) Effects of antiresorptive treatment on nonvertebral fracture outcomes. J\u00a0Bone Miner Res 26:2411\u20132418","journal-title":"J Bone Miner Res"},{"key":"994_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.bonr.2020.100729","author":"C-H Wu","year":"2020","unstructured":"Wu\u00a0C\u2011H et al (2020) Pharmacologic intervention for prevention of fractures in osteopenic and osteoporotic postmenopausal women: systemic review and meta-analysis. Bone Rep. https:\/\/doi.org\/10.1016\/j.bonr.2020.100729","journal-title":"Bone Rep"},{"key":"994_CR22","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1007\/s00198-020-05325-z","volume":"31","author":"SR Cummings","year":"2020","unstructured":"Cummings\u00a0SR, Eastell\u00a0R (2020) Stop (mis)classifying fractures as high- or low-trauma or as fragility fractures. Osteoporos Int 31:1023\u20131024","journal-title":"Osteoporos Int"}],"container-title":["Der Internist"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-021-00994-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00108-021-00994-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-021-00994-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,27]],"date-time":"2021-04-27T14:04:35Z","timestamp":1619532275000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00108-021-00994-2"}},"subtitle":["Bew\u00e4hrtes und Neues"],"short-title":[],"issued":{"date-parts":[[2021,3,12]]},"references-count":22,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["994"],"URL":"https:\/\/doi.org\/10.1007\/s00108-021-00994-2","relation":{},"ISSN":["0020-9554","1432-1289"],"issn-type":[{"value":"0020-9554","type":"print"},{"value":"1432-1289","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,12]]},"assertion":[{"value":"16 February 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"F.\u00a0Thomasius gibt an, in den vergangenen 24\u00a0Monaten Honorare f\u00fcr Beratung, Studienteilnahmen, Advisory-Board-Teilnahmen, Vortr\u00e4ge und Reisekosten von den Firmen Amgen, Gedeon Richter, Lilly, Hexal, Kyowa Kirin, Hologic, Novartis, Synexus, STADA, Theramex und UCB erhalten zu haben. B.\u00a0B\u00fchring gibt an, Reisespesen, Forschungsgelder und Vortragshonorare von den Firmen GE\/LUNAR, KineMed, Janssen, UCB, Lilly, AbbVie, Gilead und MSD erhalten zu haben.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}